Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index rose nearly 9 percent in July as stocks and indices rebounded from their Brexit-induced June falls on good earnings news and a surprise acquisition. July's performance reversed the half-percent dip the Index saw in June, with all but three companies showing stock gains for the month.

The Index outperformed the Dow Jones Industrial Average and the Nasdaq, which rose nearly 3 percent and 7 percent respectively. However, the GWDN Index underperformed the Nasdaq Biotechnology Index, which gained nearly 13 percent in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.